Gastrointestinal Environment Intelligent‐Responsive Nanozyme for the Treatment of Multidrug‐Resistant Helicobacter pylori Infection
Small · 2025-11 · 21 (44)
DOI: 10.1002/smll.202505845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 18.09.2025. Verfasst von Ke Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Engineering, Haojing College of Shaanxi University of Science & Technology, Xianyang, Shaanxi, 712046, P. R. China. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Drug Resistance, Multiple, Bacterial, Gastrointestinal Tract. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Youth Talent Support Program of Shaanxi Association for Science and Technology, Xianyang Key Research and Development Plan project, Science and Technology Youth Stars Project of Shaanxi University of Chinese Medicine.
Abstract (Originalsprache)
Helicobacter pylori is a pathogen that can withstand the pH levels in the stomach and cause gastric infections. It is widely recognized as a major risk factor for gastric diseases, and its eradication could effectively treat peptic ulcers and gastritis, and reduce the mortality rate of gastric cancer. However, the antibiotic combination therapies typically used to eradicate H. pylori can disrupt the gut microbiota. Therefore, this study presents a gastrointestinal environment intelligent‐responsive nanozyme (CeOSL) for treatment of multidrug‐resistant H. pylori infections and regulation of inflammation. The oxidase‐like activity of CeOSL is activated in the gastric juice and mucus, which generates superoxide radicals that eradicate H. pylori . Furthermore, CeOSL can scavenge reactive oxygen species to alleviate inflammation in the gastric epithelium with no significant effect on symbiotic microbiota, which addresses the pathological conditions associated with H. pylori infections. This pH‐modulated nanozyme approach provides a safer and more effective strategy for treatment of H. pylori infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Engineering, Haojing College of Shaanxi University of Science & Technology, Xianyang, Shaanxi, 712046, P. R. China.
- Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi & Education Ministry, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712083, P. R. China.
ORCID-Profile: Shuming Li
Förderung
- Youth Talent Support Program of Shaanxi Association for Science and Technology
- Xianyang Key Research and Development Plan project
- Science and Technology Youth Stars Project of Shaanxi University of Chinese Medicine
- Research and Innovation Team of Haojing College
- Shaanxi University of Science and Technology
- National Natural Science Foundation of China
- Shaanxi University of Chinese Medicine
Zitieren
APA
Wang, K., Sun, S., Tang, X., Jiao, H., Weng, J., Xu, H., Li, S., & Lv, M. (2025). Gastrointestinal Environment Intelligent‐Responsive Nanozyme for the Treatment of Multidrug‐Resistant Helicobacter pylori Infection. Small, 21(44). https://doi.org/10.1002/smll.202505845
Vancouver
Wang K, Sun S, Tang X, Jiao H, Weng J, Xu H, et al. Gastrointestinal Environment Intelligent‐Responsive Nanozyme for the Treatment of Multidrug‐Resistant Helicobacter pylori Infection. Small. 2025;21(44). doi:10.1002/smll.202505845
BibTeX
@article{Wang2025,
author = {Wang, Ke and Sun, Shiru and Tang, Xiaobing and Jiao, Honghong and Weng, Jingyu and Xu, Hongbo and Li, Shuming and Lv, Ming},
title = {Gastrointestinal Environment Intelligent‐Responsive Nanozyme for the Treatment of Multidrug‐Resistant Helicobacter pylori Infection},
journal = {Small},
year = {2025},
volume = {21},
number = {44},
doi = {10.1002/smll.202505845}
}
EUVIMED